Vaccinia Virus E3L Protein Is an Inhibitor of the Interferon (IFN)-Induced 2-5A Synthetase Enzyme  by Rivas, Carmen et al.
Vaccinia Virus E3L Protein Is an Inhibitor of the Interferon
(IFN)-Induced 2-5A Synthetase Enzyme
Carmen Rivas, Jesu´s Gil, Zora Meˇlkova´,1 Mariano Esteban,2 and Margarita Dı´az-Guerra3
Centro Nacional de Biotecnologı´a, CSIC, Campus Universidad Auto´noma, Madrid-28049, Spain
Received December 5, 1997; returned to author for revision December 29, 1997; accepted February 4, 1998
Induction of apoptosis in mammalian cells by double-stranded (ds) RNA-dependent enzymes, protein kinase (PKR), and
2-5A-synthetase/RNase L (referred to as the 2-5A system) might be a mechanism mediating anticellular and antiviral actions
of interferon (IFN). To counteract the effect of IFN, animal viruses have acquired genes that block specific IFN pathways.
Among poxviruses, vaccinia virus (VV) encodes E3L, a dsRNA-binding protein, which inhibits activation of IFN-induced PKR.
It has been proposed that E3L might also block activation of the 2-5A system, but direct proof is lacking. To establish if E3L
inhibits the 2-5A system, we have developed a method to assay apoptosis induced by increased production of enzymes in
the 2-5A pathway, as well as of their putative modulators. This assay is based on the use of cells derived from homozygous
PKR knockout mice (Pkr2/2) infected with a VV mutant lacking E3L (DE3L) and transiently transfected with a luciferase
reporter gene together with plasmid vectors expressing 2-5A-synthetase, RNase L, or E3L, all controlled by the same
inducible promoter. We found that expression of 2-5A-synthetase inhibited luciferase activity in a dose–response manner,
reaching inhibition values of 80% relative to transfections with control plasmids. Similar results were obtained by transfection
with an RNase L vector, although in this case the extent of inhibition was further enhanced upon coexpression of
2-5A-synthetase and RNase L. Inhibition of protein synthesis mediated by the 2-5A system correlated well with induction of
apoptosis. Transfection of cells with a plasmid vector expressing E3L together with 2-5A-synthetase completely prevented
apoptosis induced by this enzyme. We conclude that VV E3L acts as an inhibitor of the IFN-induced 2-5A-synthetase enzyme.
© 1998 Academic Press
INTRODUCTION
Interferon (IFN) is the host primary defense mecha-
nism of mammalian cells against viral infection or a
variety of other stimuli. Cells are stimulated to produce
and secrete IFN probably alerted by double-stranded
(ds) RNA, a frequent intermediate during virus infec-
tion (reviewed by Jacobs and Langland, 1996). Binding
of IFN to cell surface receptors initiates a signal trans-
duction pathway that culminates with induction of
more than 30 different proteins (Joklik, 1990; Samuel,
1991; Sen and Lengyel, 1992). Among the best char-
acterized are two dsRNA-dependent enzymes, 68-kDa
protein kinase (PKR) and 2-5A-synthetase, which to-
gether with 2-5A-dependent endoribonuclease L
(RNase L) establish two antiviral pathways in the host
cell (reviewed in Staeheli, 1990; Sen and Lengyel,
1992). Although basal levels of these proteins are
found in most, if not all, mammalian cells, treatment
with IFN induces at least four different forms of 2-5A-
synthetase and unique PKR and RNase L polypeptides
(reviewed in Sen and Lengyel, 1992). The PKR pathway
is constituted of this serine/threonine kinase that be-
comes activated by autophosphorylation in the pres-
ence of dsRNA and ATP, resulting in inhibition of pro-
tein synthesis by phosphorylation of the a subunit of
the eukaryotic initiation factor eIF-2 (reviewed in
Proud, 1995). In the 2-5A pathway, dsRNA activates the
2-5A-synthetases that, in the presence of ATP, synthe-
size a complex mixture (referred to as 2-5A) of 59-
triphosphorylated oligoadenylic acid, ppp(A29p5)nA,
that binds to and activates RNase L for cleavage of
viral and cellular RNAs, with the result of general
inhibition of protein synthesis (Samuel, 1991).
Induction of apoptosis has been implicated as a
mechanism used by PKR and 2-5A systems to carry
out some of the antiviral and anticellular actions of
IFN. We first demonstrated with inducible vectors that,
once activated, the IFN-induced PKR could trigger
apoptosis (Lee and Esteban, 1994). Recently, three
independent reports have demonstrated that the 2-5A
synthetase/RNase L system also causes death of
mammalian cells by apoptosis (Castelli et al., 1997;
Dı´az-Guerra et al., 1997b; Zhou et al., 1997). Induction
of apoptosis has been observed in some cells treated
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with IFN-g and potential mediators of apoptosis have
been identified (Liu and Janeway, 1990; Grawunder et
al., 1993; Deiss et al., 1995). The above findings
strongly suggest that induction of apoptosis is a mech-
anism that might be used by IFN-induced enzymes to
perform some of its biological functions. Effectiveness
of apoptotic cell death as an antiviral strategy is sup-
ported by the existence of multiple genes in animal
viruses encoding proteins modulating this process
that are important in viral cytopathogenicity, replica-
tion, spread, or persistence (reviewed in Shen and
Shenk, 1995). V V has been shown to be relatively
resistant to the antiviral effects of IFN in most cell
lines tested (Paez and Esteban, 1984; Rice et al., 1984)
due to virus-encoded proteins that work at two differ-
ent levels (reviewed by Smith, 1994): proteins that are
released from the cells as analogs of type I and II IFN
receptors, blocking IFN action at a very early stage
(Alcami and Smith, 1995; Symons et al., 1995), or
polypeptides that remain intracellular and modulate
the PKR and 2-5A pathways. Among the latter is the VV
E3L gene, which has been described as necessary for
both the V V IFN-resistant phenotype (Chang et al.,
1992; Beattie et al., 1995) and inhibition of apoptosis
(Lee and Esteban, 1994). This gene encodes two pro-
teins of 20 and 25 kDa that are expressed early in
infection (Yuwen et al., 1993) and have dsRNA binding
activity (Chang et al., 1992). E3L inhibits activation of
PKR in vivo and in vitro, presumably by sequestering
dsRNA (Chang et al., 1992). Contrary to the wild-type
virus, a V V mutant lacking the E3L gene (DE3L) in-
duces apoptosis in HeLa cells (Lee and Esteban,
1994), probably by the accumulation of dsRNA late in
infection, a byproduct which has been shown recently
to act as a trigger of apoptosis (Kibler et al., 1997). In
L929 cells, infection with DE3L results in rRNA cleav-
age characteristic of activation of the 2-5A pathway,
indicating that the polypeptides encoded by the E3L
gene might also act as inhibitors of the 2-5A-syn-
thetase activity (Beattie et al., 1995). Although experi-
mental evidence has been provided for E3L as an
inhibitor of PKR (Chang et al., 1992), its role as a
putative inhibitor of 2-5A synthetase remains to be
demonstrated.
In this investigation, we have addressed the question
as to whether the products of E3L act as inhibitors of the
2-5A pathway. In order to establish a direct effect of E3L
over the 2-5A pathway, we have taken advantage of
cultured cells obtained from mice with a knockout PKR
gene (Yang et al., 1995). Here, we describe a transient
transfection system that provides the means to define
directly if apoptosis due to activation of the 2-5A pathway
can be blocked by E3L. Our results point to E3L as a key
VV protein modulating the 2-5A system.
RESULTS
Expression of PKR in monkey BSC-40 cells causes
degradation of rRNA with the pattern characteristic of
RNase L activation
We have previously demonstrated that activation of
endogenous RNase L or increased production of en-
zymes in the 2-5A pathway causes degradation of rRNA
into characteristic discrete fragments that correlated
with apoptosis (Diaz-Guerra et al., 1997a,b). In the course
of these experiments, we noted that induction of PKR
expression not only caused the death of monkey cells by
apoptosis as already described for HeLa cells (Lee and
Esteban, 1994), but also fragmentation of rRNA indicative
of activation of the 2-5A pathway. To investigate this
effect, monkey kidney BSC-40 cells were infected with
recombinant VV expressing IFN-induced enzymes or
with a mutant VV deleted in the E3L gene and total RNA
(Fig. 1A) or cytoplasmic low-molecular-weight DNA was
analyzed (Fig. 1B). As already described, cells infected
with VV-RL, a recombinant VV that contains the RNase L
FIG. 1. Overexpression of PKR in monkey BSC-40 cells results in
cleavage of rRNA. Monolayers of BSC-40 cells were either mock
infected (lane 1) or single infected with 4 PFU/cell of viruses vT7 (lane
2), DE3L (lane 4), or VV-68K in either the absence (lane 5) or the
presence of 1.5 mM IPTG (lane 6) or doubly infected with 2 PFU/cell
each vT7 plus V V-RL (lane 3). Except for DE3L (14 h), infections
proceeded for 24 h. (A) Analysis of RNA degradation. Total RNA was
purified using the Ultraspec-II RNA Resin Purification System (Biotecx),
and the amount of RNA corresponding to 8 3 105 cells was fractionated
in 1% agarose–formaldehyde gels and stained with ethidium bromide.
Abundant RNAs, 28 S and 18 S rRNA, are indicated. (B) Analysis of
intranucleosomal DNA fragmentation. Low-molecular-weight DNA was
prepared and the amount corresponding to 3 3 106 cells electropho-
resed in an agarose gel and visualized by staining with ethidium
bromide.
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gene under the control of a bacteriophage T7 promoter
(Diaz-Guerra et al., 1997a), presented both cleavage of
rRNA and internucleosomal DNA fragmentation only
upon coinfection with a second VV recombinant (vTF7-3,
herein vT7) that contains the T7 RNA polymerase gene
controlled by a virus constitutive promoter (Fuerst et al.,
1986) (Fig. 1, lane 3). Nucleic acid fragmentation was due
to production of RNase L, since it was not observed in
mock-infected cells (Fig. 1, lane 1) or in cells infected
with vT7 (Fig. 1, lane 2). Infection of BSC-40 cells with
mutant VV lacking the E3L gene (vP1080, herein DE3L)
(Beattie et al., 1995) resulted in DNA fragmentation (Fig.
1B, lane 4), as previously described in HeLa cells (Lee
and Esteban, 1994), together with rRNA fragmentation
similar to the results obtained in mouse L929 cells (Be-
attie et al., 1995) (Fig. 1A, lane 4). Noteworthy was the
fact that infection with V V-68K, a recombinant VV encod-
ing the PKR gene under the control of an inducible
promoter (Lee and Esteban, 1993), not only induced in-
ternucleosomal DNA fragmentation upon IPTG addition
(Fig. 1B, compare lanes 5 and 6) as already described
(Lee and Esteban, 1994), but also intense cleavage of
rRNA (Fig. 1A, compare lanes 5 and 6) with the pattern
that is characteristic of activation of the 2-5A pathway.
The results obtained in L929 cells infected with DE3L
were interpreted by Beattie et al. (1995) as suggestive of
VV E3L proteins having both PKR and 2-5A-synthetase
inhibitory activity. However, in view of our findings with
VV-68K in monkey cells, cleavage of RNA in cells in-
fected with DE3L could be due to direct activation of the
2-5A system or to PKR-mediated activation of the 2-5A
system. Therefore, it was important to establish if E3L,
besides its known role as an inhibitor of PKR, is also an
inhibitor of 2-5A-synthetase.
Infection with DE3L induces apoptosis of cells lacking
PKR
If induction of apoptosis by DE3L was only the conse-
quence of activation of endogenous PKR, then this mu-
tant virus would not be able to cause apoptosis in cells
lacking PKR. To test this hypothesis, we infected mouse
fibroblasts derived from a homozygous PKR knockout
mouse (Pkr2/2) (Yang et al., 1995) with WR or DE3L and
analyzed the presence of morphological changes asso-
ciated with the apoptotic process (Wyllie et al., 1980) by
staining of nuclei with the fluorescent DNA binding dye
Hoechst 33258 (Fig. 2A) or quantified the extent of inter-
nucleosomal DNA fragmentation using an ELISA test
(Fig. 2B). As shown in Fig. 2A, cells infected with DE3L for
48 h present altered and highly condensed nuclei that
were clearly distinguishable as the cytophatic effect of
VV infection, observed in cells infected with WR, or
mock-infected cells. At earlier times, 24 h after infection,
no differences in morphology were observed between
cells infected with wild-type virus or DE3L (data not
shown). Quantitation of DNA fragmentation confirmed
these results: Pkr2/2 cells infected with DE3L for 24 h
had absorbance values similar to those obtained for WR
(Fig. 2B, top), while at 48 h there was a 3.5-fold increase
by DE3L (Fig. 2B, bottom). The experiments of Fig. 2
demonstrate that apoptosis is induced by mutant VV
DE3L in cells lacking PKR, although at very late times of
infection (48 h). Because death is not due to PKR but
probably caused by activation of the 2-5A pathway, these
results strongly suggest a role of E3L in the inhibition of
the 2-5A pathway.
Transient transfection assay to analyze induction of
apoptosis by activation of the 2-5A pathway
To follow induction of apoptosis by activation of the
2-5A system, we adapted a simple assay that has been
used to test genes encoding putative apoptosis regula-
tory proteins and is based on the analysis of their effect
upon coexpression with reporter genes (Memon et al.,
1995). We have already shown that increased production
of enzymes in the 2-5A pathway by VV vectors or acti-
vation of endogenous enzymes induces apoptosis of
mammalian cells (Diaz-Guerra et al., 1997a). To directly
demonstrate if VV E3L proteins were able to inhibit
2-5A-synthetase, and therefore interfere with induction of
apoptosis due to activation of the 2-5A pathway, we first
sought to establish an appropriate transient transfection
assay for analysis. Monolayers of mouse Pkr2/2 cells
were infected with DE3L virus and transfected with plas-
mid pPR15, containing the luciferase reporter gene under
the control of VV late promoter p4b (Rodriguez and
Smith, 1990), together with increasing amounts of p2-
5AS, a plasmid encoding human 40-kDa 2-5A-synthetase
controlled by an IPTG-inducible p4b promoter. In this
experiment, the total DNA concentration was maintained
the same in all assays using the parental plasmid pPR35
(Rodriguez and Smith, 1990), the vector used for pPR15
and p2-5AS cloning. Infections proceeded for 24 h in the
presence of IPTG, a time when apoptosis due to DE3L
infection is not yet apparent (see above), and luciferase
activity was determined in cell extracts. The results pre-
sented in Fig. 3A demonstrate that expression of 2-5A-
synthetase inhibits synthesis of luciferase in a dose–
response manner: transfection of 0.2 mg of p2-5AS al-
ready caused a 54% reduction in luciferase activity
compared to control cells transfected only with pPR35.
Luciferase expression was 58, 79, and 80% of control
values in cells transfected, respectively, with 0.5, 1.0, and
2.0 mg of p2-5AS. These results demonstrate that recom-
binant 2-5A-synthetase inhibits protein synthesis, an ef-
fect not due to activation of endogenous PKR.
To further confirm that inhibition of protein synthesis
by increased production of 2-5A-synthetase was due to
activation of the 2-5A pathway, we analyzed the effect
that synthesis of RNase L, another enzyme in this IFN-
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induced pathway, has on reporter gene expression.
Mouse Pkr2/2 and Pkr1/1 cells were infected with DE3L
and transfected as before with pPR15 and different com-
binations of p2-5AS and/or pRL, a plasmid containing the
human RNase L gene under the control of the VV IPTG-
inducible p4b promoter. By using an amount of reporter
gene that was 10 times lower than the amounts of p2-
5AS or pRL, we favored the expression of luciferase
together with 2-5A-synthetase or RNase L. The same
total amount of DNA was maintained in all assays using
pPR35 and infections proceeded for 24 h in the presence
of IPTG. Cell extracts were prepared and luciferase ac-
tivity was determined (Fig. 3B). We observed, respec-
tively, a 33 and 60% reduction of luciferase activity due to
increased production of RNase L and 2-5A-synthetase
compared to cells transfected with pPR35. As seen be-
fore with the recombinant viruses (Diaz-Guerra et al.,
1997a), combined production of 2-5A-synthetase and
RNase L further enhanced their individual effects on
protein synthesis, reaching 95% inhibition of luciferase
expression.
Next we wanted to confirm that inhibition of protein
synthesis by transient transfection of enzymes in the
2-5A pathway correlated with induction of apoptosis.
Cells grown in coverslips were infected/transfected as
before and fragmentation of DNA was analyzed by
TUNEL assay (Fig. 3C). Intense fluorescence indicative
of apoptosis was clearly detected in cells transfected
with pRL, p2-5AS, or pRL 1 p2-5AS in the presence of
inducer, while only a very few cells were stained in its
absence, probably due to some promoter leakage. The
results in Fig. 3 demonstrate that transient expression of
enzymes in the 2-5A pathway induces apoptosis in cells
lacking PKR and establish the experimental conditions to
directly test the role of VV E3L in the activation of 2-5A-
synthetase.
Transient expression of the VV E3L gene inhibits
apoptosis due to activation of the 2-5A pathway
To directly determine if E3L was able to inhibit 2-5A-
synthetase, we performed transient transfection of the
E3L gene in Pkr2/2 cells infected with the DE3L virus as
before. We used pPR15 and different combinations of
p2-5AS and/or pE3L, a plasmid containing the VV E3L
gene under the control of the V V IPTG-inducible p4b
promoter. The same total amount of DNA was main-
tained in all assays using pPR35 and infections pro-
ceeded for 24 h in the presence of IPTG. Cell extracts
were prepared and luciferase activity was determined
FIG. 2. Induction of apoptosis by DE3L in cells lacking PKR. (A)
3T3-like cells derived from homozygous PKR knockout mice (Pkr2/2)
grown on coverslips were either mock infected (top) or infected with
WR (middle) or DE3L (bottom) (m.o.i. 4): After 48 h, the cells were fixed,
permeabilized, stained with Hoechst 33258, and photographed. (B)
Extent of apoptosis by ELISA test. Cells were infected for 24 or 48 h as
before, extracts obtained, and absorbance at 405 nm was determined.
Mean values with standard deviations are given.
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FIG. 3. Induction of apoptosis by transient expression of enzymes in the 2-5A pathway. (A) Dose–response of inhibition of reporter gene expression
by transient transfection of 2-5A-synthetase. Pkr2/2 cells grown in 12-well plates were infected with DE3L (m.o.i. 5) and transfected 1 h later with 0.2
mg of plasmid pPR15 together with 0.0, 0.1, 0.2, 0.5, 1.0, or 2.0 mg of p2-5AS as indicated. A total concentration of 2 mg/well of DNA was maintained
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(Fig. 4A). Reduction of luciferase activity by increased
production of 2-5A-synthetase was 60% compared to
cells transfected with pPR35. Transfection of the E3L
gene had no significant effect on luciferase expression
by itself, as seen by comparison to control cells, but
coexpression with 2-5A-synthetase completely pre-
vented inhibition of protein synthesis induced by this
enzyme. In order to demonstrate that E3L proteins were
also able to inhibit apoptosis induced by 2-5A-syn-
thetase, we performed a TUNEL assay (Fig. 4B). Cells
grown in coverslips were infected/transfected as before
and fragmentation of DNA was analyzed. Fluorescence
indicative of apoptosis was clearly detected only in cells
transfected with p2-5AS in the presence of IPTG. Expres-
sion of VV E3L together with 2-5A-synthetase completely
inhibited induction of apoptosis by this enzyme. These
results directly demonstrate that VV-encoded E3L pro-
teins are able to inhibit dsRNA-activated 2-5A-synthetase
together with PKR.
DISCUSSION
Since PKR and 2-5A-synthetase are both dsRNA-de-
pendent enzymes it was reasonable to assume that VV
E3L, a protein able to inhibit PKR by sequestration of
dsRNA (Chang et al., 1992), would also inhibit 2-5A-
synthetase. This assumption was also based on the
observation that infection of mouse L929 cells with VV
deletion mutant DE3L induced cleavage of rRNA into the
discrete fragments that are characteristic of RNase L
activation (Beattie et al., 1995). However, this hypothesis
has not been directly demonstrated. Moreover, since we
have found in monkey cells that activation of PKR also
causes activation of the 2-5A pathway by a mechanism
not yet understood (Fig. 1), the role of E3L in modulation
of the 2-5A pathway needed to be examined in cells that
do not express PKR. In this investigation, we have de-
veloped a transient-transfection system to assay apopto-
sis induced by activation of the 2-5A pathway, which is
based on the use of cells derived from homozygous PKR
knockout mice (Pkr2/2) infected with DE3L virus. In this
way, the contribution of 2-5A-synthetase, RNase L,
and/or E3L to apoptosis could be directly evaluated. Our
results demonstrate that VV E3L protein has a dual
function in inhibition of PKR and 2-5A-synthetase and,
therefore, plays a critical role in modulation of the two
main IFN-induced antiviral and anticellular pathways.
Protein E3L is produced at early times in cultured cells
infected with wild-type VV (Yuwen et al., 1993) and, con-
sequently, is present in the cell before late transcription
starts and the majority of dsRNA is synthesized (Colby et
al., 1971). This is understandable since the virus has to
counteract the excess dsRNA produced during infection
which, in turn, will activate the IFN response. While in
Chinese hamster ovarian cells (Ink et al., 1995) infection
with wild-type VV induces apoptosis, in many cell lines it
does not (manuscript in preparation), indicating that E3L
and/or other virus products efficiently regulate the PKR
and 2-5A pathways. Since 2-5A is produced at high
levels late during infection (Rice et al., 1984; Esteban and
Paez, 1985), and is biologically active both in vitro (Rice
et al., 1984) and in vivo (Diaz-Guerra et al., 1997a), we
have proposed the existence of an additional mecha-
nism of modulation of the 2-5A pathway (Diaz-Guerra et
al., 1997a). According to this hypothesis, E3L should
regulate 2-5A-synthetase while another protein(s), not
yet identified, would be directly responsible for interfer-
ence with RNase L. The reason for the accumulation of
2-5A in cells that are producing E3L and the requirement
for an additional ‘‘safety’’ mechanism of modulation of the
2-5A pathway need to be further investigated. We believe
that during infection with VV of mammalian cells there is
a tightly regulated equilibrium among levels of the IFN-
inducible proteins (endogenous, IFN-induced, or overex-
pressed), their activators (dsRNA or 2-5A), and virus-
encoded interference products. Subtle changes in the
levels of some of these components seem to be critical
in directing the host cell toward apoptosis. Different data
support this idea: expression of recombinant PKR (Lee
and Esteban, 1994) or RNase L (Castelli et al., 1997;
Diaz-Guerra et al., 1997b), synthesis of increased levels
of dsRNA (Kibler et al., 1997; Diaz-Guerra et al., 1997b)
and expression of E3L (Lee and Esteban, 1994) all con-
stitute modulators of apoptosis.
The strain WR of VV encodes at least another protein that
interferes with apoptotic cell death. Protein SPI-2, the prod-
uct of ORF B13R, is highly homologous to the cowpox virus
(CPV) cytokine response modifier (crm A), a specific inhib-
itor of the interleukin-1b converting enzyme (ICE) (Ray et al.,
1992). Since crm A has been shown to inhibit apoptosis
induced by many different stimuli (reviewed in White, 1996),
this CPV protein has been fundamental in establishing the
importance of caspases in this form of death. It has been
by using plasmid pPR35. Infections proceeded in the presence of 1.5 mM of IPTG for 24 h and then cells were collected and luciferase production
was determined as described. All assays were carried out in triplicate and mean values with standard deviations are given. (B) Inhibition of reporter
gene expression by transient transfection of 2-5A-synthetase and/or RNase L. Pkr2/2 or Pkr1/1 cells infected as above were transfected with 0.2 mg
of pPR15 together with 4 mg of pPR35 or with 2 mg each one of the following plasmids: pRL1pPR35, p2-5A1 pPR35, pRL1p2-5A. Infections proceeded
in the presence of 1.5 mM of IPTG for 24 h and luciferase production was determined as described. All assays were carried out in triplicate and mean
values with standard deviations are given. (C) Inhibition of reporter gene expression by enzymes in the 2-5A pathway correlates with apoptosis of
transfected cells. Pkr2/2 cells grown on cover slides were infected/transfected as described in B, in the presence or the absence of IPTG. A TUNEL
assay was performed as indicated and fields representative of independent assays are shown.
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recently shown that SPI-2 is able to protect HeLa cells
against apoptosis induced by treatment with Fas ligand or
tumour necrosis factor (TNF) with cycloheximide (CHX)
(Dobbelstein and Shenk, 1996) but not CHX alone (Kettle et
al., 1997). Since CHX induces apoptosis in uninfected HeLa
cells but not in cells infected with WR or infected with a
deletion mutant in gene B13R, it has been suggested that a
component of the virus particle might be preventing apop-
tosis under these conditions (Kettle et al., 1997). It is pres-
ently unknown if there is any relationship between these
proteins and E3L or, on the contrary, they are required in the
modulation of independent pathways of apoptosis induc-
tion.
MATERIALS AND METHODS
Cells and viruses
African green monkey kidney cell line BSC-40 was
grown in Dulbecco’s modified medium (DMEM) supple-
mented with 10% newborn calf serum. Mouse fibroblasts
derived from homozygous PKR knockout mice (Yang et
al., 1995) were obtained from C. Weissmann and grown
in DMEM supplemented with 10% fetal calf serum. Cells
were cultivated at 37°C with 5% CO2. Virus vTF7-3 (here-
in vT7) contains the bacteriophage T7 RNA polymerase
gene under the control of a virus constitutive promoter as
described (Fuerst et al., 1986). The recombinant virus
VV-RL was obtained by insertion of plasmid pTM-RL into
the tk region of wild-type VV (strain WR) by homologous
recombination, as shown before (Dı´az-Guerra et al.,
1997a). It encodes the human RNase L gene containing
a stretch of six histidine residues at the N-terminus
under the control of T7 promoter. The recombinant virus
VV-68K expresses PKR under lacI repressor/operator
controlling elements (Lee and Esteban, 1993). Vaccinia
E3L deletion mutant vP1080 (DE3L) has been previously
described (Beattie et al., 1995) and was kindly provided
by Enzo Paoletti. This virus was grown and titered using
chicken embryo fibroblasts (CEF) as described else-
where (Tartaglia et al., 1992).
Plasmid vectors
Plasmid pPR15 contains the luciferase reporter gene
under the control of VV p4b late promoter as previously
described (Rodriguez and Smith, 1990). Other plasmids
used for transient transfection of cells were derived from
insertion vector pPR35 designed for isopropyl-b-D-thio-
galactoside (IPTG)-inducible expression of genes (Rod-
riguez and Smith, 1990). Plasmid pRL was generated by
insertion of a HindIII fragment of ZC-5 containing the
human RNase L gene (Zhou et al., 1993) into the SmaI
site of pPR35 as described (Diaz-Guerra et al., 1997a).
Plasmid p2-5AS was obtained by insertion of a DNA
fragment containing complete human 40-kDa 2-5A-syn-
thetase cDNA, except for nucleotides coding the first of
two methionine residues at the N terminus, into the SmaI
site of pPR35. The region coding for E3L was isolated by
amplification of DNA obtained from BSC-40 cells infected
with wild-type VV (WR), using polymerase chain reaction
with primers 59-CCGGATCCCGATGTCTAAAATCTATAT-
CG-39 and 59-GCGGTACCCCTCAGAATCTAATGATGA-
CG-39 that added, respectively, BamHI and Asp718 sites
FIG. 4. Expression of E3L inhibits apoptosis induced by 2-5A-syn-
thetase. (A) Synthesis of E3L prevents inhibition of reporter gene
expression due to 2-5A-synthetase activity. Pkr2/2 cells grown in 12-
well plates were infected with DE3L (m.o.i. 5) and transfected 1 h later
with 0.2 mg/well pPR15 together with 2.0 m g/well pE3L, 0.5 m g/well
p2-5AS, or pE3L (2.0 mg/well) plus p2-5AS (0.5 mg/well) in the presence
of IPTG. A total concentration of 2.7 mg/well of DNA was maintained by
using plasmid pPR35 when required. After 24 h, cells were collected
and luciferase was determined as above. (B) E3L inhibits apoptosis
induced by 2-5A-synthetase. A TUNEL assay was performed on Pkr2/2
cells infected as before, in the presence or the absence of IPTG.
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at the end of this gene. The amplification product di-
gested with those enzymes (593 bp) was first cloned into
plasmid pUC118, restricted in the same way, and con-
firmed by DNA sequencing. Thereafter, the E3L gene
was subcloned into pPR35 using the same restriction
enzymes as described above.
Analysis of low-molecular-weight DNA
Low-molecular-weight DNA was isolated from cul-
tured cells as described (Hirt, 1967) and analyzed by 1.6%
agarose gel electrophoresis containing 0.1 mg/ml
ethidium bromide in Tris–acetate/EDTA (Lee and Es-
teban, 1994).
Total RNA isolation
Total cellular RNA from mock-infected or infected cells
was isolated using Ultraspec-II RNA Resin Purification
System (Biotecx). For analysis, denatured RNA was frac-
tionated on 1% formaldehyde–agarose gels and stained
using ethidium bromide buffer (Diaz-Guerra et al., 1997a).
Measurement of the extent of apoptosis
The Cell Death Detection ELISA kit from Boehringer
Mannheim was used according to the manufacturer’s
instructions. This assay is based on the quantitative
sandwich enzyme immunoassay principle and uses
mouse monoclonal antibodies directed against DNA and
histones, respectively, to estimate the amount of cyto-
plasmic histone-associated DNA.
Hoechst staining
Cells were grown on coverslips and fixed 48 h after
infection using 4% sucrose, 4% formaldehyde in PBS for
15 min at room temperature. Fixed cells were then per-
meabilized for 5 min at room temperature with 0.25%
Triton X-100 in PBS, stained with fluorescent DNA bind-
ing dye Hoechst 33258 (0.5 mg/ml), and photographed
with a fluorescence microscope.
Transient transfection of mouse cells lacking
endogenous PKR
Semiconfluent mouse Pkr2/2 cells derived from trans-
genic animals, grown in 12-well plates, were infected
with 5 PFU/cell of DE3L virus and transfected 1 h later
with 0.2 mg of pPR15 per well plus the indicated amounts
of pPR35-derived plasmids using lipofectamine (GIBCO),
according to manufacturer’s directions. When noted
IPTG (1.5 mM) was added to the cultures at the time of
transfection. Cells were harvested 24 h after infection
and lysed, and luciferase activity was determined as
previously described (Braiser et al., 1989).
TUNEL assay
A terminal deoxynucleotidyltransferase-mediated
dUTP nick end labeling (TUNEL) assay was performed
on Pkr2/2 cells as described (Gavrieli et al., 1992).
Briefly, cells were grown to 50% confluence on glass
coverslips, infected/transfected as above, and then fixed
and permeabilized as described for Hoechst staining.
After washing in PBS, fixed cells were treated for 1 h at
37°C with terminal transferase (Promega) and deoxyuri-
dine covalently linked to digoxigenin (Boehringer Mann-
heim). Detection was performed incubating with 50
mg/ml streptavidin Cy3 (Jackson Immunoresearch Labs)
at room temperature for 30 min. After additional washes
with PBS, cells were photographed under a fluorescence
microscope.
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